Please view this important announcement regarding Estimate Data. Click here.

TEVA

Dividend Champions a Rare Undervalued Opportunity

2012-01-06

Research Articles

We believe that based on earnings, 2012 is starting out with the stock market undervalued. We believe in the long-term ownership of great businesses purchased at sound and attractive valuations. Consequently, we view the stock market as merely the store that we shop at in order to buy the businesses we want to own. Furthermore, […]

America’s Best Companies are Cheap – So Merry Christmas and a Prosperous New Year!

2011-12-19

Research Articles

Let there be no confusion about the purpose and intent of this article.  It is intended to present a positive and enthusiastic defense and a reasoned support of our great country and its economic strength and promise.  There are far too many that want to criticize and denigrate our economy and the very system within […]

8 Strong Growth Stocks Significantly Under-valued by Mr. Market

2011-09-01

Research Articles

Positioning Statements and Principles We don’t believe in investing in the stock market.  Instead, we believe in investing in great businesses.  Therefore, we tend to focus more on how the business is performing on an operating basis than we do on stock price volatility.  In other words, we are most interested in whether or not […]

Teva Pharmaceutical Has It All: Value, Growth and Yield

2011-01-15

Research Articles

Headquartered in Israel, Teva (TEVA) is the world’s largest generic drug maker, which markets over 1200 molecules in over 60 countries throughout the world. In addition to their generic portfolio, Teva also possesses a strong branded portfolio led by Copaxone, the world’s leading injectable therapy for multiple sclerosis. Teva generates high levels of cash flow, […]

Health Care Beneficiaries!

2009-09-14

Videos

Health care is a hot topic today. Regardless of the outcome for reform there are companies that are poised to benefit. I am referring to companies that are part of the solution by helping to reduce costs. Today’s video looks at a few excellent companies that should thrive regardless of healthcare reform. Best when viewed in […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.